A mathematical model to predict nanomedicine pharmacokinetics and tumor delivery

A mathematical model to predict nanomedicine pharmacokinetics and tumor delivery

Towards clinical translation of cancer nanomedicine, it is important to systematically investigate the various parameters related to nanoparticle (NP) physicochemical properties, tumor characteristics, and inter-individual variability that affect the tumor delivery efficiency of therapeutic nanomate...

Full description

Bibliographic Details
Main Authors:	Prashant Dogra, Joseph D. Butner, Javier Ruiz Ramírez, Yao-li Chuang, Achraf Noureddine, C. Jeffrey Brinker, Vittorio Cristini, Zhihui Wang
Format:	Article
Language:	English
Published:	Elsevier 2020-01-01
Series:	Computational and Structural Biotechnology Journal
Subjects:	Cancer nanotherapy Enhanced permeability and retention effect Mechanistic mathematical modeling PBPK Pharmacokinetics Sensitivity analysis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2001037019305653

Similar Items

Physiologically Based Pharmacokinetics Model in Pregnancy: A Regulatory Perspective on Model Evaluation
by: Paola Coppola, et al.
Published: (2021-06-01)

Review of the pharmacokinetics of nanodrugs
by: Shao Xiaotong, et al.
Published: (2023-03-01)

Mechanistic Modeling of Placental Drug Transfer in Humans: How Do Differences in Maternal/Fetal Fraction of Unbound Drug and Placental Influx/Efflux Transfer Rates Affect Fetal Pharmacokinetics?
by: Xiaomei I. Liu, et al.
Published: (2021-10-01)

Unravelling bisphenol A pharmacokinetics using physiologically based pharmacokinetic modeling
by: Xiaoxia eYang, et al.
Published: (2015-01-01)

Localization of drug biodistribution in a 3D-bioengineered subcutaneous neovascularized microenvironment
by: Simone Capuani, et al.
Published: (2022-12-01)

Clopidogrel Pharmacokinetics in Malaysian Population Groups: The Impact of Inter-Ethnic Variability
by: Zaril H. Zakaria, et al.
Published: (2018-07-01)

Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy
by: Wei Li, et al.
Published: (2020-12-01)

Physiologically Based Pharmacokinetics Modeling in the Neonatal Population—Current Advances, Challenges, and Opportunities
by: Jean Dinh, et al.
Published: (2023-11-01)

Physiologically Based Pharmacokinetic Modeling of Extracellular Vesicles
by: Prashant Kumar, et al.
Published: (2023-08-01)

A Physiologically Based Pharmacokinetic Model to Predict Determinants of Variability in Epirubicin Exposure and Tissue Distribution
by: Radwan Ansaar, et al.
Published: (2023-04-01)

Construction of dual nanomedicines for the imaging and alleviation of atherosclerosis
by: Shuihua Zhang, et al.
Published: (2020-01-01)

Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies
by: Sara Sánchez-Molina, et al.
Published: (2022-11-01)

A physiologically based pharmacokinetic model for V937 oncolytic virus in mice
by: Sara Peribañez-Dominguez, et al.
Published: (2023-09-01)

Physiologically Based Pharmacokinetic Modeling in Pregnant Women Suggests Minor Decrease in Maternal Exposure to Olanzapine
by: Liang Zheng, et al.
Published: (2022-01-01)

Physiologically Based Pharmacokinetic (PBPK) Model of Gold Nanoparticle-Based Drug Delivery System for Stavudine Biodistribution
by: Hinojal Zazo, et al.
Published: (2022-02-01)

Prediction of a Therapeutic Dose for Buagafuran, a Potent Anxiolytic Agent by Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Starting from Pharmacokinetics in Rats and Human
by: Fen Yang, et al.
Published: (2017-10-01)

Development of a Region-Specific Physiologically Based Pharmacokinetic Brain Model to Assess Hippocampus and Frontal Cortex Pharmacokinetics
by: Zaril Zakaria, et al.
Published: (2018-01-01)

Utility of Physiologically Based Pharmacokinetic Modeling to Investigate the Impact of Physiological Changes of Pregnancy and Cancer on Oncology Drug Pharmacokinetics
by: Xinxin Yang, et al.
Published: (2023-12-01)

Physiologically Based Pharmacokinetic Modelling and Simulation to Predict the Plasma Concentration Profile of Doxorubicin
by: George A. Mystridis, et al.
Published: (2022-02-01)

Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen
by: Ioannis Loisios-Konstantinidis, et al.
Published: (2020-11-01)

Pharmacokinetics and Disposition of Heparin-Binding Growth Factor Midkine Antisense Oligonucleotide Nanoliposomes in Experimental Animal Species and Prediction of Human Pharmacokinetics Using a Physiologically Based Pharmacokinetic Model
by: Haihong Bai, et al.
Published: (2021-11-01)

Application of Modelling and Simulation Approaches to Predict Pharmacokinetics of Therapeutic Monoclonal Antibodies in Pediatric Population
by: Andrew Lim, et al.
Published: (2023-05-01)

Pharmacokinetics of PEGylated Gold Nanoparticles: In Vitro—In Vivo Correlation
by: Tibor Dubaj, et al.
Published: (2022-02-01)

Predicting Volume of Distribution in Neonates: Performance of Physiologically Based Pharmacokinetic Modelling
by: Pieter-Jan De Sutter, et al.
Published: (2023-09-01)

Exposure of Infants to Isoniazid via Breast Milk After Maternal Drug Intake of Recommended Doses Is Clinically Insignificant Irrespective of Metaboliser Status. A Physiologically-Based Pharmacokinetic (PBPK) Modelling Approach to Estimate Drug Exposure of Infants via Breast-Feeding
by: Estella Dora Germaine Garessus, et al.
Published: (2019-01-01)

Vinblastine pharmacokinetics in mouse, dog, and human in the context of a physiologically based model incorporating tissue‐specific drug binding, transport, and metabolism
by: Sandra Witta, et al.
Published: (2023-02-01)

A physiologically based pharmacokinetic/pharmacodynamic model to determine dosage regimens and withdrawal intervals of aditoprim against Streptococcus suis
by: Kun Mi, et al.
Published: (2024-04-01)

Role of Nanomedicine in Redox Mediated Healing at Molecular Level
by: Adhikari Aniruddha, et al.
Published: (2019-10-01)

Therapy of rheumatoid arthritis by reactive oxygen species-responsive celastrol-loaded nanomedicines via targeting macrophages apoptosis
by: Sen Lin, et al.
Published: (2022-12-01)

Pharmacokinetics and Pharmacodynamics of T-Cell Bispecifics in the Tumour Interstitial Fluid
by: Miro Julian Eigenmann, et al.
Published: (2021-12-01)

Challenges Related to Acquisition of Physiological Data for Physiologically Based Pharmacokinetic (PBPK) Models in Postpartum, Lactating Women and Breastfed Infants—A Contribution from the ConcePTION Project
by: Martje Van Neste, et al.
Published: (2023-11-01)

Analysis of Time-Dependent Pharmacokinetics Using In Vitro–In Vivo Extrapolation and Physiologically Based Pharmacokinetic Modeling
by: Min-Chang Kim, et al.
Published: (2022-11-01)

Prediction of CYP-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Modeling: A Case Study of Salbutamol and Fluvoxamine
by: Lara Marques, et al.
Published: (2023-05-01)

Development of a Minimalistic Physiologically Based Pharmacokinetic (mPBPK) Model for the Preclinical Development of Spectinamide Antibiotics
by: Keyur R. Parmar, et al.
Published: (2023-06-01)

A compatibility evaluation between the physiologically based pharmacokinetic (PBPK) model and the compartmental PK model using the lumping method with real cases
by: Hyo-jeong Ryu, et al.
Published: (2022-08-01)

Recent advances in nanomedicine preparative methods and their therapeutic potential for colorectal cancer: a critical review
by: Arinjay Jain, et al.
Published: (2023-06-01)

Implementation of a Physiologically Based Pharmacokinetic Modeling Approach to Guide Optimal Dosing Regimens for Imatinib and Potential Drug Interactions in Paediatrics
by: Jeffry Adiwidjaja, et al.
Published: (2020-01-01)

Editorial: Pharmacokinetic evaluation and modeling of clinically significant drug metabolites, Volume II
by: Momir Mikov, et al.
Published: (2023-01-01)

Generic Workflow to Predict Medicine Concentrations in Human Milk Using Physiologically-Based Pharmacokinetic (PBPK) Modelling—A Contribution from the ConcePTION Project
by: Nina Nauwelaerts, et al.
Published: (2023-05-01)

Pharmacokinetic bias analysis of an association between clinical thyroid disease and two perfluoroalkyl substances
by: Michael W. Dzierlenga, et al.
Published: (2020-08-01)